Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

The rise of deadly insect sting allergies: Is there a cure?

01.08.2013
Report suggests venom immunotherapy can make sufferers 'less allergic'

If you think summer insects are done setting their sights on ruining your outdoor gathering, think again. August's hot and dry climate is the perfect breeding ground for insects, especially yellow jackets. And for the millions of Americans allergic to insect stings, these late summer bugs can be deadly.

According to a report released today in the August issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI), insect sting allergy is increasing, affecting five percent of the population. But what much of the population may not understand is that there is something that can be done about it.

"While it does not always cure insect sting allergy, venom immunotherapy, a form of allergy shots, can almost always prevent severe reactions to stings," said David Golden, MD, article author and ACAAI fellow. "It usually provides long-lasting immunity even after the treatment is stopped."

Even 10 to 20 years after having an allergic reaction from an insect sting, the chance of having another reaction continues to be up to 70 percent in adults and 30 percent in children. Venom immunotherapy doesn't completely eliminate the risk of an allergic reaction to insect stings, noted Dr. Golden, but almost all of the reactions that do occur (five to 10 percent) are mild, with less than two percent chance of a severe reaction while on treatment. Protection takes effect as soon as the full dose is reached, usually within 2 to 3 months of treatment.

"Allergy sufferers who have had an allergic reaction to an insect sting should be under the care of a board-certified allergist," said Dr. Golden. "For those with severe reactions, prescribed emergency epinephrine should always be carried. Sufferers should also talk with their allergist to see if venom immunotherapy is right for them. It's not always a cure, but it is close."

As with other forms of allergy shots, the recommended duration of venom immunotherapy is three to five years. Because relapse can occur, it's best for patients to be regularly tested by an allergist. Venom immunotherapy actually prevents severe reactions, and improves quality of life because people no longer have to fear getting stung.

To reduce the chance of getting stung by late summer insects, the ACAAI advises:

Cover up with pants and long-sleeved shirts when gardening or working outdoors
Avoid walking barefoot in the grass
Take caution when eating or drinking anything sweet
Don't wear sweet smelling perfumes, hairsprays and deodorants when heading outdoors

Avoid brightly colored clothing with floral patterns

For more information about insect sting allergy and to locate an allergist in your area, visit http://www.AllergyAndAsthmaRelief.org.

About ACAAI

The ACAAI is a professional medical organization of more than 5,700 allergists-immunologists and allied health professionals, headquartered in Arlington Heights, Ill. The College fosters a culture of collaboration and congeniality in which its members work together and with others toward the common goals of patient care, education, advocacy and research. ACAAI allergists are board-certified physicians trained to diagnose allergies and asthma, administer immunotherapy, and provide patients with the best treatment outcomes. For more information and to find relief, visit http://www.AllergyandAsthmaRelief.org. Join us on Facebook, Pinterest and Twitter.

Nancy Ryan | EurekAlert!
Further information:
http://www.acaai.org

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>